In Silico Modeling of Myelin Oligodendrocyte Glycoprotein Disulfide Bond Reduction by Phosphine-Borane Complexes
Background: Neurodegenerative diseases can cause vision loss by damaging retinal ganglion cells in the optic nerve. Novel phosphine-borane compounds (PBs) can protect these cells from oxidative stress via the reduction of disulfide bonds. However, the specific targets of these compounds are unknown....
Saved in:
| Main Authors: | Raheem Remtulla, Sanjoy Kumar Das, Leonard A. Levin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/11/1417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An atypical cause of optic neuritis: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
by: Mark A. Colantonio, MD, et al.
Published: (2025-07-01) -
Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as aseptic meningitis and multiple cranial neuritis: a case report
by: Yi-Na Zhang, et al.
Published: (2025-07-01) -
The Clinical and Radiologic Features of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOGAD) in the City of Sakarya, Türkiye
by: Saadet Sayan, et al.
Published: (2025-07-01) -
The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study
by: Jiafei Cheng, et al.
Published: (2025-03-01) -
Targeted steroid delivery for myelin oligodendrocyte glycoprotein antibody-associated rare optic neuritis: Clinical outcome and review literature
by: Shweta Singh, et al.
Published: (2025-04-01)